Aimed Alliance, and twenty-eight other organizations asked the U.S. District Court for the District of Columbia to accept their amicus…
In 2022, Aimed Alliance recognized that health disparities exist in the inflammatory bowel disease (“IBD”) patient population. With rates of…
The Medication Access and Training Expansion (MATE) Act was incorporated into the Consolidated Appropriations Act of 2023. This bill requires…
On December 29, 2022, President Biden signed the Consolidated Appropriations Act of 2023. Section 1264 amended Section 309A(a)(5) of the…
On November 2, Aimed Alliance hosted a legislative briefing on facilitating access to medications for opioid use disorders (“MOUD”). The…
On October 17, 2022, the New York Step Therapy Alliance hosted a roundtable meeting to discuss the current state of…
On November 2, 2022, Aimed Alliance hosted a legislative briefing on facilitating access to medications for opioid use disorders (“MOUD”).…
The open enrollment periods for individual, small, large group, and Medicare plans have recently opened for 2023 enrollment! To ensure…
Join Aimed Alliance for a FREE webinar on February 9, 2022 at 1:00PM ET – 2:00PM ET. You are invited…
On September 7, 2021, the California legislature passed SB-110. SB-110 would allow the California state Medicaid program, Medi-Cal, to provide contingency management as a covered benefit for treating substance use…